Desmosterol

Desmosterol is an activator of LXR used in studies of NF-kB Signaling and Immune Signaling and related signaling programs. It is especially relevant in cardiovascular, endocrinology, and immunology models, where defined compound exposure can be linked to inflammatory transcriptional control and stress-responsive survival signaling and cytokine-mediated signaling and inflammatory effector responses.

By activating LXR, Desmosterol can be used to examine inflammatory transcriptional control and stress-responsive survival signaling and cytokine-mediated signaling and inflammatory effector responses. The nuclear receptor annotation adds relevance to reporter-gene, receptor-binding, and transcriptional assays, together with downstream-response mapping in the same experimental setting. In cardiovascular, endocrinology, and immunology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving LXR
• Pathway perturbation studies connected to NF-kB Signaling and Immune Signaling and related signaling programs
• Gain-of-function pathway-activation studies
• Reporter-gene, receptor-binding, and transcriptional assays

Overall, Desmosterol is appropriate when a defined chemical perturbant is needed to connect LXR with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cardiovascular, endocrinology, and immunology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.